EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical, morphological, and molecular characterization of patients with X-linked myopathy with excessive autophagy (XMEA)

Angèle N Merlet iD, Emmanuelle Lacène, Isabelle Nelson, Guy Brochier, Clémence Labasse, Anais Chanut, Angeline Madelaine, Maud Beuvin, Gisèle Bonne iD, Léonard Féasson, Marie-Christine Minot, Jean-Baptiste Noury und 9 weitere

Journal of Neuropathology & Experimental Neurology · 01.04.2026 · 85 (4) · 351-362

DOI: 10.1093/jnen/nlaf134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, online erschienen am 27.11.2025. Verfasst von Angèle N Merlet und 20 weiteren Autor:innen. Beteiligte Einrichtung: Myology Unit, Reference Center for Neuromuscular Diseases, Euro-NMD, Department of Clinical Physiology and Exercice, University Hospital of Saint-Eti…. Hauptthemen laut MEDLINE: Autophagy, Muscular Diseases, Genetic Diseases, X-Linked. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Gesellschaft für Muskelkranke (DGM), European Regional Development Fund (ERDF; project NME-GPS and B2B-RARE), Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

X-linked myopathy with excessive autophagy (XMEA) is a slowly progressive disease affecting male patients, caused by hemizygous mutations in the VMA21 gene. We studied nine patients from six unrelated French families clinically suspected of having XMEA. Clinical charts were reviewed, and muscle biopsies underwent histological, immunohistochemical, and electron microscopy analysis. Sanger sequencing and next generation VMA21 gene panels were performed, and proteomic profiling was done on muscle extracts from two patients. Clinical onset ranged from childhood to adulthood with most showing proximal lower limb weakness and mild creatine kinase elevation. Three patients had cardiac and respiratory involvement. Muscle biopsies revealed cytoplasmic vacuoles, split fibers, internalized nuclei and variable fiber sizes. Vacuoles stained positively for sarcolemmal and autophagic proteins, as well as for complement C5b-9. Ultrastructural analysis showed basal lamina duplication, subsarcolemmal vacuoles, and extensive autophagosome extrusion. Proteomic analysis revealed complement activation, impaired proteolysis, and mitochondrial/cytoskeletal vulnerabilities. Biglycan and thrombospondin-4 were identified as potential novel diagnostic markers. Molecular studies found two known pathogenic variants (c.164-7T>G and c.163 + 4A>G) and a novel 3′UTR variant (c.*124A>G) in VMA21. This study expands the clinical spectrum of XMEA by reporting adult-onset cases, a novel mutation, and highlights the value of proteomics in understanding the pathophysiology of XMEA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyMuscular DiseasesGenetic Diseases, X-LinkedHumansMaleAdultChildAdolescentYoung AdultMuscle, SkeletalMutationMiddle AgedFemaleVacuolar Proton-Translocating ATPases

Stichwörter der Autor:innen

VMA21X-linked myopathy with excessive autophagyXMEAautophagic vacuolar myopathyproteomicskeletal muscleultrastructure

Substanzen

VMA21 protein, humanVacuolar Proton-Translocating ATPases

Autor:innen und Institutionen

  • Myology Unit, Reference Center for Neuromuscular Diseases, Euro-NMD, Department of Clinical Physiology and Exercice, University Hospital of Saint-Etienne, Saint-Priest-en-Jarez, France.
  • Interuniversity Laboratory of Human Movement Biology, Jean-Monnet University, Saint-Etienne, France.
  • Functional Unit of Neuromuscular Pathology, Department of Neuropathology, Institut de Myologie, GHU Pitié-Salpêtrière, Paris, France.
  • Sorbonne University, Inserm, Institut de Myologie, Centre de Recherche en Myologie, Paris, France.
  • Neuromuscular Competence Center, University Hospital of Rennes, Rennes, France.
  • Reference Centre for Neuromuscular Diseases AOC, University Hospital of Brest, Brest, France.

ORCID-Profile: Angèle N Merlet, Gisèle Bonne, Mélanie Fradin, Marco Savarese, Tanya Stojkovic, Teresinha Evangelista

Förderung

  • Deutsche Gesellschaft für Muskelkranke (DGM)
  • European Regional Development Fund (ERDF; project NME-GPS and B2B-RARE)
  • Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen
  • Der Regierende Bürgermeister von Berlin, Senatskanzlei Wissenschaft und Forschung
  • European Union's Horizon 2020 research and innovation programme
  • ERDF
  • European Union’s Horizon 2020 research and innovation programme

Zitieren

APA

Merlet, A. N., Lacène, E., Nelson, I., Brochier, G., Labasse, C., Chanut, A., Madelaine, A., Beuvin, M., Bonne, G., Féasson, L., Minot, M. C., Noury, J. B., Fradin, M., Savarese, M., Fernández-Eulate, G., Behin, A., Stojkovic, T., Hentschel, A., Marcorelles, P., …, & Evangelista, T. (2026). Clinical, morphological, and molecular characterization of patients with X-linked myopathy with excessive autophagy (XMEA). Journal of Neuropathology & Experimental Neurology, 85(4), 351-362. https://doi.org/10.1093/jnen/nlaf134

Vancouver

Merlet AN, Lacène E, Nelson I, Brochier G, Labasse C, Chanut A, et al. Clinical, morphological, and molecular characterization of patients with X-linked myopathy with excessive autophagy (XMEA). Journal of Neuropathology & Experimental Neurology. 2026;85(4):351-362. doi:10.1093/jnen/nlaf134

BibTeX
@article{Merlet2026,
  author = {Merlet, Angèle N and Lacène, Emmanuelle and Nelson, Isabelle and Brochier, Guy and Labasse, Clémence and Chanut, Anais and Madelaine, Angeline and Beuvin, Maud and Bonne, Gisèle and Féasson, Léonard and Minot, Marie-Christine and Noury, Jean-Baptiste and Fradin, Mélanie and Savarese, Marco and Fernández-Eulate, Gorka and Behin, Anthony and Stojkovic, Tanya and Hentschel, Andreas and Marcorelles, Pascale and Roos, Andreas and Evangelista, Teresinha},
  title = {Clinical, morphological, and molecular characterization of patients with X-linked myopathy with excessive autophagy (XMEA)},
  journal = {Journal of Neuropathology & Experimental Neurology},
  year = {2026},
  volume = {85},
  number = {4},
  pages = {351--362},
  doi = {10.1093/jnen/nlaf134}
}
Kostenlos starten →